• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    PDLLA length on anti-breast cancer efficacy of acid-responsive self-assembling mPEG-PDLLA-docetaxel conjugates

    2023-10-14 02:54:30ToLiuHuiZouJingqingMuXiZhngGuohuLiuYuBoYunXioyongYunXingjiLingShutoGuo
    Chinese Chemical Letters 2023年9期

    To Liu, Hui Zou, Jingqing Mu, Xi Zhng, Guohu Liu, N Yu, Bo Yun,Xioyong Yun,c,d,?, Xingji Ling, Shuto Guo,?

    a Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China

    b School of Medicine, Nankai University, Tianjin 300071, China

    c Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China

    d Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Institute, Tianjin Eye Hospital, Tianjin 300020, China

    e CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing 100190, China

    Keywords:Nanomedicine Prodrug Docetaxel mPEG-PDLLA Acid-sensitive

    ABSTRACT Engineering small-molecule drugs into nanoparticulate formulations provides an unprecedented opportunity to improve the performance of traditional chemo drugs, but suffers from poor compatibility between drugs and nanocarriers.Stimuli-responsive mPEG-PDLLA-drug conjugate-based nanomedicines can facilitate the exploitation of beneficial properties of the carrier and enable the practical fabrication of highly efficacious self-assembled nanomedicines.However, the influence of hydrophobic length on the performance of this type of nanomedicine is little known.Here we synthesized two acid-sensitive ketal-linked mPEG-PDLLA-docetaxel prodrugs with different lengths of PDLLA, and engineered them into self-assembled sub-20 nm micellar nanomedicines for breast cancer chemotherapy.We found that the nanomedicine consisting of a mPEG-PDLLA-docetaxel prodrug with the shorter length of PDLLA stood out due to its potent cytotoxicity, deep penetration into multicellular spheroids, and improved in vivo anticancer performance.Additionally, our prodrug-based nanomedicines outperformed the generic formulation of commercial Nanoxel in terms of safety profile, tolerated doses, and tumor suppression.Our findings indicate that the hydrophobic content of a polymeric prodrug nanomedicine plays an important role in the performance of the nanomedicine, and should be instructive for developing polymeric prodrug-based nanomedicines with clinical translational potential.

    Exploiting the advantages of nanotechnology, engineering small-molecule drugs into nanoparticulate formulations (i.e.,nanomedicines) provides an unprecedented opportunity to enhance the performance of traditional chemotherapeutic drugs and to screen new drug candidates [1-4].Conventionally, encapsulation of hydrophobic drugs into the matrix of the hydrophobic part of an amphiphilic copolymer represents a simple and appealing strategy for nanomedicine fabrication [5].For instance, methoxy polyethylene glycol-block-poly(D,l-lactide) (mPEG-PDLLA), a biodegradable and biocompatible copolymer, has been successfully exploited to develop two taxane micellar formulations (Genexol for paclitaxel and Nanoxel for docetaxel (DTX)) [6], boosting the massive studies for developing nanomedicines of various drugs by using mPEGPDLLA or its analogs [7].However, limited success has been achieved because this strategy requires excellent compatibility between small-molecule drugs and amphiphilic carriers.Moreover,nanomedicines suffer from low loading efficiency and poor colloidal stability bothin vitroandin vivo[8,9].

    Strategies such as changing the composition of amphiphilic polymers (e.g., ratios of hydrophobic combinations, the length of the hydrophobic segment, and the structure of the unit) [10,11],optimizing processing methods [10], and cross-linking the core[12] have been attempted to improve the compatibility between drugs and the core of the nanocarrier.Although microfluidic devices can considerably expedite the high-throughput screening of nanomedicines [13], the development of nanomedicines using the above-mentioned strategies is essentially formulation-driven and inherently inflexible.As an alternative, developing prodrug-based nanomedicines is a modular approach, and conjugating chemo drugs onto the polymers through a chemical linkage can avoid the poor compatibility issue [14].More importantly, this approach can exploit the beneficial properties of nanocarriers and thus facilitate the development of highly efficacious nanomedicines.For example, mPEG-PDLLA can self-assemble into small-sized nanoparticles of appropriate composition, with strong barrier-penetrating capability [15].Thus, mPEG-PDLLA-drug conjugates may enable the practical fabrication of highly efficacious nanomedicines without complex synthesis, and are therefore appealing.Although the structure-in vivofate relationship of mPEG-PDLLA (and analogous polymers) and their physically drug-loaded nanomedicines are extensively studied, and some mPEG-PDLLA-drug conjugates have been reported [7,8,16-18], the influence of hydrophobic content on the performance of nanomedicines has, unexpectedly, rarely been investigated and revealed.

    Here two mPEG-PDLLA-ketal-DTX prodrugs (DKPPs) were synthesized by conjugating DTX to the end of the PDLLA block of mPEG-PDLLA through a ketal linkage, using a coppercatalyzed azide-alkyne cycloaddition reaction.mPEG2k-PDLLA1.8kand mPEG2k-PDLLA3.5kwere used to construct DKPP1.8kand DKPP3.5k, respectively, which were further engineered to micellar sub-20 nm nanomedicines named DKPP1.8k-Mic and DKPP3.5k-Mic(Fig.1).The size, acid-sensitivity, andin vitroandin vivoanticancer performance of DKPP-Mics were systematically investigated.We found that the hydrophobic content of DKPP significantly affected the anticancer performance of DKPP-Mic: A shorter length of PDLLA and a higher critical micelle concentration (CMC) led to better outcomes.

    Fig.1.Construction and evaluation of DKPP micellar nanomedicines (DKPP-Mics).(a) Two DKPPs were constructed with ketal linkage and self-assembled into micellar nanomedicines (DKPP-Mic) with different sizes due to the difference in PDLLA length.(b) Anticancer evaluation of DKPP-Mic in a subcutaneous 4T1-Luc breast cancer mouse model after intravenous injection, and the cancer cell-killing mechanism of DKPP-Mic.

    DKPP1.8kand DKPP3.5kwere synthesized using the combinational methodology of an acid-catalytic ketal construction strategy[19] and click chemistry (Schemes S1-S3 in Supporting information).The hydrophilic content of DKPP1.8kand DKPP3.5kwas 41 wt% and 30 wt%, respectively, which should confer different CMC values.The structure of these DKPPs was confirmed by NMR, in which the characteristic peaks of PEG (δ3.6,1H NMR), PDLLA(δ5.2, 1.5,1H NMR), and the ketal linkage (δ102,13C NMR)were observed (Figs.S1-S3 in Supporting information).Our synthetic approach was straightforward to conduct and would be applicable to other hydroxyl-group-bearing hydrophobic drugs.Amphiphilic DKPP could self-assemble into micellar formulations with a surface composed of PEG and a core composed of DTX-ketal-PDLLA (Fig.2a).DKPP-Mics were prepared by the nanoprecipitation method.For comparison, DTX-Mic was also prepared by physically encapsulating DTX into the core of mPEG-PDLLA micelles according to the preparation procedure of Nanoxel, a commercial micellar DTX formulation that uses mPEG2k-PDLLA1.8kas the carrier [20].Compared with DTX-Mic (4.8 wt%), the drug content of DKPP1.8k-Mic (15.2 wt%) and DKPP3.5k-Mic (11.4 wt%) is increased by 2.4-3.2-fold (Table S1 in Supporting information).More importantly,DKPP-Mics displayed reasonable colloidal stability and could be stored at 4°C for two weeks, facilitating their use for intravenous administration.The hydrophobic content is a critical factor in regulating the hydrodynamic diameter of micelles.Compared with blank mPEG2k-PDLLA1.8kMic (12.7 nm), DKPP1.8k-Mic demonstrated a similar size (13.6 nm), while DTX-Mic (15.5 nm) and DKPP3.5k-Mic (18.6 nm) were slightly bigger (Fig.2b, Fig.S4 and Table S1 in Supporting information).Meanwhile, the particle size was confirmed by TEM, and was slightly smaller than that determined by DLS (Figs.2c and d, Fig.S5 in Supporting information).Besides, the PDIs of DKPP-Mics were about 0.3.Although DKPP did not carry any charge, DKPP-Mics exhibited negative zeta potentials because of the PEG surface (Table S1), which might facilitate their long blood circulation.

    Fig.2.Characterization of DTX formulations.(a) Preparation of DKPP-Mics using the nanoprecipitation technique.(b) DLS of DKPP-Mics and DTX-Mic.(c) TEM images of DKPP-Mics.(d) Size of micelles from (c); 100 micelles were measured.(e)Hydrolysis mechanism of DKPP.Hydrolysis curves of DKPP-Mics at (f) pH 5.0 and (g)pH 7.4.The half-life (t1/2) of each DKPP is shown on the graph.Data are presented as means ± SDs (n=4).

    CMC can determine the colloidal stability of a micelle and is considered as an indicator ofin vivoperformance for physically drug-loaded micellar formulations [21].Theoretically, micelles with lower CMC values will be more stable upon dilution and favorable for more prolonged blood circulation.Compared with unconjugated mPEG2k-PDLLA1.8k(CMC=3.19 μmol/L), the CMC of DTX conjugated DKPP1.8k(0.75 μmol/L) was markedly reduced by 4.2-fold because of a higher hydrophobic content (Table S1 and Fig.S6 in Supporting information).As expected, when the hydrophobic content was raised by increasing the PDLLA length, DKPP3.5kdemonstrated a lower CMC value (0.51 μmol/L) than DKPP1.8k.

    Ketal-linked prodrugs may be activated in acidic environments to release native drug under the catalysis of acid (Fig.2e).To study the hydrolysis kinetics of DKPP, DKPP-Mics at a concentration of 0.4 mmol/L (above the CMCs of DKPPs) were incubated in pH 5.0 buffer and pH 7.4 buffer, and the hydrolysis of DKPP was monitored by HPLC.After incubation for 8 h, more than 80% of DKPPs were hydrolyzed at pH 5.0 while less than 5% were hydrolyzed at pH 7.4, and the hydrolysis rate of DKPPs at pH 5.0 was 72-107 times faster than that at pH 7.4 (Figs.2f and g, Fig.S7 and Table S2 in Supporting information).Compared with our previously reported PEGylated taxane prodrugs [22], DKPP-Mics demonstrated slower prodrug hydrolysis kinetics (3.5-5.7 times slower at pH 5.0),indicating that the introduction of the hydrophobic PDLLA segment endowed a more compact core and increased the colloidal stability.Surprisingly, we found that DKPP3.5k-Mic with a higher hydrophobic content displayed faster hydrolysis kinetics than DKPP1.8k-Mic.At pH 5.0 and pH 7.4, thet1/2values of DKPP1.8k-Mic (3.1 h and 223 h, respectively) were 1.7-fold and 1.2-fold higher than those of DKPP3.5k-Mic (1.8 h and 193 h, respectively), which may be attributed to a difference in the PEG chain density and conformation on the micellar surface.Compared with DKPP1.8k-Mic, DKPP3.5k-Mic was larger in particle size, with a lower density of PEG on the surface.PEG is probably in a “brush” configuration on the surface of DKPP1.8k-Mic and extends away from the surface, whereas it is probably in a “mushroom” configuration on the surface of DKPP3.5k-Mic and localizes more closely to the surface [23,24], facilitating the infiltration of protons into the core of the micelles to trigger ketal hydrolysis.

    To evaluate thein vitroanticancer efficacy of DTX formulations, the cytotoxicity of DTX and DTX formulations against 4T1-Luc cells was assessed.DTX-Mic (IC50=14 nmol/L) displayed comparable cytotoxicity to DTX (IC50=13 nmol/L), while DKPP-Mics showed slightly decreased cytotoxicity (IC50=18 and 25 nmol/L)(Fig.3a).The IC50value of DKPP3.5k-Mic (IC50=25 nmol/L) was 1.4 times higher than that of DKPP1.8k-Mic (IC50=18 nmol/L) (Fig.3a)even though DKPP3.5k-Mic demonstrated fasterin vitrohydrolysis kinetics; this may be attributed to a difference in cellular uptake profiles.DTX is an inhibitor of microtubule depolymerization [6].To investigate the cell-killing mechanism of DKPP, 4T1-Luc cells were incubated with DTX or DTX formulations (500 nmol/L, 6 h),and the microtubules and nuclei were stained with tubulin-trackerred and DAPI, respectively, for visualization using CLSM (Fig.3b).Compared with untreated cells, in which microtubules were extended in the cytoplasm, cells treated with DTX and DTX formulations displayed higher proportions of cells with aggregated microtubules (Fig.3b and Fig.S8 in Supporting information).To further investigate the cellular uptake of DKPP-Mics, 4T1-Luc cells were incubated with DKPP-Mic (10 μmol/L, 6 h).As shown in Fig.3c,compared with DKPP1.8k-Mic, DKPP3.5k-Mic demonstrated a 1.4-fold lower cellular uptake of total equivalent DTX (Ctotal), which explains the low cytotoxicity of DKPP3.5k-Mic.Besides, DKPP1.8k-Mic and DKPP3.5k-Mic displayed similar degrees of intracellular prodrug hydrolysis (91% and 87%, respectively), even though DKPP3.5k-Mic demonstrated a fasterin vitrohydrolysis rate in buffer solutions.These results indicate that DKPPs can be effectively activated inside the cell.

    Nanoparticles with smaller sizes may achieve better penetration[25,26].To investigate thein vitrotumor penetration of DKPP-Mics,4T1-Luc multicellular 3D tumor spheroids were incubated with Cy5-labelled DKPP formulations (namedCy5DKPP-Mics, Scheme S4 in Supporting information) at 500 nmol/L for 12 h, and the penetration into spheroids and cellular uptake ofCy5DKPP-Mic were then determined by CLSM and flow cytometry, respectively.As visualized in Fig.3d,Cy5DKPP1.8k-Mic penetrated more deeply into tumor spheroids.Meanwhile, we investigated the cellular uptake ofCy5DKPP-Mics by tumor spheroids.As shown in Figs.3e and f,the proportion of Cy5-positive cells treated withCy5DKPP1.8k-Mic(61.8%) was 2.3 times higher than that treated withCy5DKPP3.5k-Mic (26.7%).These results indicated that compared with DKPP3.5k-Mic, DKPP1.8k-Mic demonstrated superiorin vitroanticancer efficacy, with higher cellular uptake and deeper penetration in tumor spheroids.

    Fig.3. In vitro evaluation of DTX formulations.(a) Cytotoxicity of DTX formulations against 4T1-Luc cells (n=3).(b) 4T1-Luc cells were treated with drugs, and the microtubules and nucleus were stained with tubulin-tracker-red and DAPI, respectively (magnification: 800×).(c) Cellular uptake of drugs determined by HPLC (n=4).Free DTX indicates the concentration of DTX released inside cells.The extent of hydrolysis (%) is indicated.(d, e) Multicellular 3D tumor spheroids were treated with Cy5DKPPMics (500 nmol/L, 12 h) to assess the penetration ability of DKPP-Mic by (d) CLSM and (e) flow cytometric analysis.(f) Percentages of Cy5-positive cells measured by flow cytometry (n=3).Data are presented as means ± SDs; ?P ≤0.05; ????P ≤0.0001.

    Fig.4. In vivo anticancer evaluation of DTX formulations.(a) Establishment of 4T1-Luc breast tumor-bearing mouse model and the treatment schedule.(b) Tumor volume and (c) survival profiles were monitored every day.(d) IVIS luminescence imaging at the end of the experiment.The dose administered was 10 mg/kg (DTX equivalent dose).(e) Body weight and (f) survival profiles of mice during MTD evaluation.(g) Tumor volume and (h) survival profiles during anticancer treatment with DTX-Mic and DKPP1.8k-Mic at their MTDs on 4T1-Luc tumor-bearing mice (n=5).Data are presented as means ± SEMs; ?P ≤0.05; ??P ≤0.01; ns, not significant.

    We further evaluated thein vivoanticancer efficacy of DTX formulations using a 4T1-Luc tumor-bearing mouse model, and all animal protocols and experiments were carried out in accordance with the guidelines approved by the Institutional Animal Care and Use Committee of Nankai University.When tumors reached about 50 mm3, mice were randomly divided into four groups and treated with PBS, DKPP1.8k-Mic, DKPP3.5k-Mic, or DTX-Mic at 10 mg/kg(DTX equivalent dose) every three days, for three doses, by tail vein injection (Fig.4a).After 14 days, mice treated with DKPP-Mics demonstrated much delayed tumor growth and improved survival profiles compared with DTX-Mic-treated mice (Figs.4b-d).The tumor inhibition rate of DTX-Mic, DKPP1.8k-Mic, and DKPP3.5k-Mic was 3.9%, 30.4%, and 20.1%, respectively (Fig.S9a in Supporting information).At the end of the experiment, no mice treated with DKPP-Mics had died, while two of five mice treated with DTX-Mic had died (Figs.4c and d).Moreover, DKPP-Mics did not cause body weight loss in the mice, while the body weight of mice treated with DTX-Mic decreased dramatically (by 14% at the end of treatment) (Fig.S9b in Supporting information).Besides, DKPP1.8k-Mic demonstrated better anticancer efficacy than DKPP3.5k-Mic, consistent with thein vitrocellular experiments in which DKPP1.8k-Mic was more cytotoxic and achieved better tumor spheroid penetration, possibly due to its smaller size [26].

    DKPP1.8k-Mic was used for subsequent investigation.To determine the maximum tolerated dose (MTD) of DKPP1.8k-Mic and DTX-Mic, healthy BALB/c mice were treated with DKPP1.8k-Mic and DTX-Mic at different dosages (Figs.4e and f).We found that DKPP1.8k-Mic could be administered up to 20 mg/kg (DTX equivalent dose) without causing mouse death or>5% body weight loss,while DTX-Mic caused dramatic body weight reduction (>15%) and death (5 of 5 mice died) at 20 mg/kg (DTX equivalent) (Fig.4f).We next investigated the anticancer efficacy of DKPP1.8k-Mic and DTXMic administered at their MTD doses (Figs.4g and h), and found that tumors treated with DTX-Mic were about 2.8 times larger than those treated with DKPP1.8k-Mic.The tumor inhibition rate of the DKPP1.8k-Mic-treated group was improved from 30.4% to 61.9%when the dose increased from 10 mg/kg to 20 mg/kg (DTX equivalent dose) (Fig.S9a), indicating the outstanding anticancer potential of DKPP1.8k-Mic.

    Although PEG-PDLLA has been widely used as the carrier for constructing self-assembling polymer-drug conjugate-based nanomedicines [7], most studies have focused on improving drug loading, optimizing linker chemistry, targeting modification, topological design, and co-delivery of drug combinations.Theoretically,a lower CMC value indicates a more stable micellar core and improved colloidal stability, resulting in prolonged blood circulation and better anticancer efficacy.Previously, Luet al.used mPEG2k-PLA4.2kand mPEG2k-PLA8.9kto construct two ester-linked mPEGPLA-SN38 conjugates, investigated the impact of PLA length on the efficacy of prodrug-based nanomedicines, and found that conjugates with longer PLA had better anticancer efficacy [18], probably due to a lower CMC value and improved colloidal stability [21].Coincidentally, our PEGylated cabazitaxel prodrug with a lower CMC value demonstrated better anticancer efficacy than that with a higher CMC value [22].Nevertheless, in this study, DKPP1.8k-Mic with a shorter PDLLA and higher CMC value showed better anticancer efficacy (Table S3 in Supporting information), perhaps due to its smaller size for enhanced penetration.Because CMC, which can be modulated by the length of PDLLA, has perplexing effects on the properties of nanomedicines, including circulation, accumulation, penetration, and cell uptake, the CMC of mPEG-PDLLA-drug conjugates should be delicately optimized in the design of highly efficacious nanomedicines.

    In summary, two acid-responsive ketal-linked self-assembling mPEG-PDLLA-DTX conjugates were constructed, to improve DTX/carrier compatibility for facilitating DTX delivery and to investigate the impact of the length of PDLLA on the performance of prodrug-based nanomedicines.DKPPs were readily self-assembled into sub-20 nm nanomedicines with good acid-responsiveness.We found that DKPP1.8k-Mic with a shorter PDLLA demonstrated betterin vitrocytotoxicity, penetration in tumor spheroids, andin vivoanticancer efficacy.Besides, DKPP-Mics outperformed the generic formulation of commercial Nanoxel in anticancer efficacy and safety profile.Our nanomedicine platform would have broad applications in the delivery of various hydroxyl group-containing drugs or their combinations, and our findings offer new insights into constructing and optimizing acid-responsive polymeric prodrug nanomedicines.

    Declaration of competing interest

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    Acknowledgments

    This work was financially supported by National Natural Science Foundation of China (Nos.32171386 and 32201157), the Natural Science Foundation of Tianjin of China (No.21JCZDJC01250), and the China Postdoctoral Science Foundation (No.2021M690793).

    Supplementary materials

    Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2023.108135.

    国产一区亚洲一区在线观看| 日本猛色少妇xxxxx猛交久久| 在线天堂最新版资源| 啦啦啦啦在线视频资源| 久久精品国产自在天天线| 国产爽快片一区二区三区| 亚洲精品久久午夜乱码| 2018国产大陆天天弄谢| 我的女老师完整版在线观看| 少妇人妻一区二区三区视频| 制服丝袜香蕉在线| 欧美+日韩+精品| 国产欧美亚洲国产| 国产男女超爽视频在线观看| 免费av不卡在线播放| 欧美xxⅹ黑人| 成人毛片a级毛片在线播放| 纵有疾风起免费观看全集完整版| 成人毛片60女人毛片免费| 交换朋友夫妻互换小说| 中文天堂在线官网| 自拍欧美九色日韩亚洲蝌蚪91 | 国产伦精品一区二区三区四那| 国产精品久久久久久久电影| xxx大片免费视频| 一本久久精品| 乱人伦中国视频| 少妇高潮的动态图| 亚洲综合色惰| 一本一本综合久久| 免费少妇av软件| 国产av精品麻豆| 日韩不卡一区二区三区视频在线| 亚洲国产最新在线播放| 国产日韩欧美在线精品| 亚洲av日韩在线播放| 国产精品国产三级国产av玫瑰| 久久午夜福利片| 国产欧美日韩一区二区三区在线 | 黄片无遮挡物在线观看| 久久青草综合色| 国产69精品久久久久777片| 欧美老熟妇乱子伦牲交| 日本午夜av视频| 色视频在线一区二区三区| 久久精品久久久久久久性| 两个人免费观看高清视频 | 狂野欧美激情性bbbbbb| 午夜免费男女啪啪视频观看| 深夜a级毛片| 日韩成人av中文字幕在线观看| 啦啦啦啦在线视频资源| 亚洲经典国产精华液单| 爱豆传媒免费全集在线观看| 简卡轻食公司| 国产伦理片在线播放av一区| 看非洲黑人一级黄片| 久久99热这里只频精品6学生| 欧美3d第一页| 久久久国产精品麻豆| 人人妻人人澡人人看| 卡戴珊不雅视频在线播放| 欧美成人精品欧美一级黄| 国产成人freesex在线| 一区在线观看完整版| 视频中文字幕在线观看| 中文字幕亚洲精品专区| 熟女电影av网| 一本色道久久久久久精品综合| 国语对白做爰xxxⅹ性视频网站| 十八禁高潮呻吟视频 | 少妇人妻精品综合一区二区| 十八禁网站网址无遮挡 | 日本91视频免费播放| 久久人妻熟女aⅴ| 国产男人的电影天堂91| 中文乱码字字幕精品一区二区三区| 99热这里只有是精品50| 婷婷色麻豆天堂久久| av天堂久久9| 少妇 在线观看| 91精品一卡2卡3卡4卡| 久久99蜜桃精品久久| 观看美女的网站| 免费看日本二区| 十八禁网站网址无遮挡 | 欧美一级a爱片免费观看看| 精品熟女少妇av免费看| 国产高清国产精品国产三级| 中文字幕亚洲精品专区| 国产成人精品久久久久久| 高清av免费在线| 黄色视频在线播放观看不卡| 欧美激情国产日韩精品一区| 少妇人妻 视频| 好男人视频免费观看在线| 高清在线视频一区二区三区| 精品人妻偷拍中文字幕| 青青草视频在线视频观看| 国产无遮挡羞羞视频在线观看| 免费看光身美女| 99热国产这里只有精品6| 热re99久久国产66热| 97在线人人人人妻| 大话2 男鬼变身卡| 人人澡人人妻人| 特大巨黑吊av在线直播| 一级毛片黄色毛片免费观看视频| a级毛片免费高清观看在线播放| 国产中年淑女户外野战色| 亚洲性久久影院| 欧美bdsm另类| 成年人午夜在线观看视频| av专区在线播放| 免费高清在线观看视频在线观看| 少妇猛男粗大的猛烈进出视频| av在线app专区| 男女免费视频国产| 欧美日韩视频高清一区二区三区二| 久热久热在线精品观看| 国产精品久久久久久久电影| 美女xxoo啪啪120秒动态图| 亚洲av综合色区一区| 精品酒店卫生间| 七月丁香在线播放| 国产淫片久久久久久久久| 日韩电影二区| 只有这里有精品99| av在线播放精品| 日日啪夜夜爽| 人妻夜夜爽99麻豆av| 亚洲精品国产成人久久av| 国产一级毛片在线| 男女免费视频国产| 在线观看国产h片| 国产一级毛片在线| 大话2 男鬼变身卡| 国精品久久久久久国模美| 国产淫语在线视频| 国产精品偷伦视频观看了| 人人澡人人妻人| 蜜桃久久精品国产亚洲av| 黑丝袜美女国产一区| 大码成人一级视频| 国产无遮挡羞羞视频在线观看| 五月开心婷婷网| 国产一区二区在线观看av| 我要看黄色一级片免费的| 成年女人在线观看亚洲视频| 3wmmmm亚洲av在线观看| 高清欧美精品videossex| 男女无遮挡免费网站观看| freevideosex欧美| 丰满少妇做爰视频| 少妇的逼水好多| 亚洲美女黄色视频免费看| 久久韩国三级中文字幕| 99久久精品一区二区三区| 少妇人妻一区二区三区视频| 日韩亚洲欧美综合| 色5月婷婷丁香| 精品国产一区二区久久| 色婷婷久久久亚洲欧美| 99国产精品免费福利视频| 日韩制服骚丝袜av| 一级黄片播放器| 国产在线免费精品| 高清av免费在线| 亚洲成人一二三区av| 人体艺术视频欧美日本| 国国产精品蜜臀av免费| 国产乱人偷精品视频| 成人毛片a级毛片在线播放| 综合色丁香网| 黄色欧美视频在线观看| 日本色播在线视频| 99久国产av精品国产电影| 欧美老熟妇乱子伦牲交| 国产一区亚洲一区在线观看| 中文字幕制服av| 国产成人精品久久久久久| 狂野欧美激情性xxxx在线观看| 蜜桃久久精品国产亚洲av| 边亲边吃奶的免费视频| 亚洲高清免费不卡视频| 中国美白少妇内射xxxbb| 免费播放大片免费观看视频在线观看| 久久久久国产精品人妻一区二区| 精品国产一区二区三区久久久樱花| 啦啦啦在线观看免费高清www| a级毛色黄片| 大陆偷拍与自拍| 亚洲精品国产色婷婷电影| 丝瓜视频免费看黄片| 日韩欧美 国产精品| 久久ye,这里只有精品| 在线亚洲精品国产二区图片欧美 | 少妇人妻 视频| 国产精品久久久久久精品电影小说| 内射极品少妇av片p| 一级毛片 在线播放| 一级黄片播放器| 欧美最新免费一区二区三区| av一本久久久久| 免费黄网站久久成人精品| 我的老师免费观看完整版| 免费大片18禁| 99久久精品一区二区三区| 免费播放大片免费观看视频在线观看| 建设人人有责人人尽责人人享有的| 欧美激情极品国产一区二区三区 | 搡女人真爽免费视频火全软件| 黄色视频在线播放观看不卡| 日本免费在线观看一区| 日本av手机在线免费观看| 一个人免费看片子| 亚洲精品,欧美精品| 国产在视频线精品| 女人久久www免费人成看片| 高清av免费在线| 熟妇人妻不卡中文字幕| 久久99蜜桃精品久久| 国产精品久久久久成人av| 色5月婷婷丁香| 国产一区亚洲一区在线观看| 中文字幕制服av| 久久热精品热| av不卡在线播放| 欧美激情国产日韩精品一区| 91久久精品国产一区二区三区| 久久精品国产a三级三级三级| 永久免费av网站大全| 91精品国产国语对白视频| 国产av一区二区精品久久| 亚洲国产av新网站| 国产精品伦人一区二区| 交换朋友夫妻互换小说| 能在线免费看毛片的网站| 麻豆成人av视频| 亚洲国产欧美在线一区| av在线app专区| 日本av免费视频播放| 在线 av 中文字幕| 夫妻性生交免费视频一级片| 国产日韩一区二区三区精品不卡 | 免费看不卡的av| 一本—道久久a久久精品蜜桃钙片| 国产亚洲一区二区精品| 国产永久视频网站| 国产亚洲精品久久久com| 久久久久久久久久成人| 国产亚洲最大av| 丝袜喷水一区| 日本wwww免费看| 最近2019中文字幕mv第一页| 日本免费在线观看一区| 高清不卡的av网站| 熟女av电影| 国产精品人妻久久久影院| 亚洲av不卡在线观看| 久久久久久久久久久久大奶| 日韩欧美精品免费久久| 国产精品.久久久| 国产视频首页在线观看| 日韩精品免费视频一区二区三区 | 高清午夜精品一区二区三区| 精品少妇内射三级| 亚洲国产精品999| 黑人高潮一二区| 在线观看www视频免费| av天堂中文字幕网| 伊人久久精品亚洲午夜| 内射极品少妇av片p| 亚洲美女黄色视频免费看| 性色avwww在线观看| 日韩欧美一区视频在线观看 | 久久久久久久精品精品| 国产日韩欧美视频二区| 色5月婷婷丁香| 日韩不卡一区二区三区视频在线| 午夜福利影视在线免费观看| 精品一品国产午夜福利视频| 欧美亚洲 丝袜 人妻 在线| 国产高清有码在线观看视频| 精品亚洲乱码少妇综合久久| 亚洲av日韩在线播放| 国产高清国产精品国产三级| 欧美 日韩 精品 国产| 欧美区成人在线视频| 少妇的逼好多水| 亚洲成人一二三区av| 亚洲欧美精品专区久久| 免费大片18禁| 亚洲国产精品国产精品| 国产女主播在线喷水免费视频网站| 中国国产av一级| 国产欧美日韩一区二区三区在线 | 亚洲精品视频女| 校园人妻丝袜中文字幕| 在线观看www视频免费| 中文资源天堂在线| 又大又黄又爽视频免费| 2021少妇久久久久久久久久久| 国产伦理片在线播放av一区| 在线精品无人区一区二区三| 日韩成人伦理影院| 美女主播在线视频| 精品少妇内射三级| 久久久国产欧美日韩av| 一级毛片黄色毛片免费观看视频| 69精品国产乱码久久久| 精品卡一卡二卡四卡免费| 久久久久久久久久久丰满| 中文字幕人妻丝袜制服| 一级a做视频免费观看| 国产乱来视频区| 久久女婷五月综合色啪小说| 一级片'在线观看视频| 免费看av在线观看网站| 亚洲成人av在线免费| 自拍欧美九色日韩亚洲蝌蚪91 | 夫妻性生交免费视频一级片| 国产亚洲午夜精品一区二区久久| 成人二区视频| 国产有黄有色有爽视频| a级毛片免费高清观看在线播放| 纯流量卡能插随身wifi吗| 亚洲av日韩在线播放| 久久99热这里只频精品6学生| 一级爰片在线观看| 22中文网久久字幕| 下体分泌物呈黄色| 久久久亚洲精品成人影院| 麻豆成人午夜福利视频| 国产女主播在线喷水免费视频网站| 亚洲欧美清纯卡通| 天堂中文最新版在线下载| 亚洲精品国产av成人精品| .国产精品久久| 午夜福利视频精品| av福利片在线观看| 精品久久久精品久久久| 日本-黄色视频高清免费观看| 亚洲国产最新在线播放| 国产精品一区二区在线观看99| 国精品久久久久久国模美| 亚洲在久久综合| 天堂8中文在线网| 日韩成人伦理影院| 天美传媒精品一区二区| 欧美激情极品国产一区二区三区 | av天堂久久9| 国产在线男女| av天堂久久9| kizo精华| 色视频在线一区二区三区| 人人妻人人爽人人添夜夜欢视频 | 在线观看免费视频网站a站| 国产亚洲91精品色在线| 青春草视频在线免费观看| 又粗又硬又长又爽又黄的视频| 国产一区有黄有色的免费视频| 国产精品国产三级国产av玫瑰| 精品亚洲成a人片在线观看| 亚洲国产精品专区欧美| 中文字幕人妻熟人妻熟丝袜美| 极品人妻少妇av视频| 成年av动漫网址| 亚洲天堂av无毛| 免费看日本二区| 日本午夜av视频| 18禁动态无遮挡网站| 26uuu在线亚洲综合色| 国产爽快片一区二区三区| 最新中文字幕久久久久| 高清在线视频一区二区三区| 国产精品人妻久久久影院| 国产免费又黄又爽又色| 男女边吃奶边做爰视频| 中国美白少妇内射xxxbb| 18禁在线播放成人免费| 精品人妻熟女毛片av久久网站| 久久青草综合色| 黄色一级大片看看| 午夜老司机福利剧场| 在线天堂最新版资源| 国产精品久久久久成人av| 国产免费福利视频在线观看| 日韩 亚洲 欧美在线| 亚洲激情五月婷婷啪啪| 成人二区视频| 又大又黄又爽视频免费| 中文字幕人妻熟人妻熟丝袜美| 97超视频在线观看视频| 午夜免费观看性视频| 亚洲精品国产成人久久av| 在线播放无遮挡| 国产综合精华液| 看免费成人av毛片| 99九九在线精品视频 | 日韩一区二区三区影片| 国产熟女欧美一区二区| 国产成人免费无遮挡视频| 久久国产精品男人的天堂亚洲 | 亚洲不卡免费看| 久久精品国产鲁丝片午夜精品| 三级国产精品欧美在线观看| 一区二区三区免费毛片| 欧美老熟妇乱子伦牲交| 精品久久久久久久久av| 97在线人人人人妻| 国产 一区精品| 菩萨蛮人人尽说江南好唐韦庄| 中文字幕免费在线视频6| 久久99蜜桃精品久久| 三级国产精品片| 日韩av在线免费看完整版不卡| 99久久精品国产国产毛片| 99视频精品全部免费 在线| 91精品国产国语对白视频| 亚洲国产日韩一区二区| 精品一区在线观看国产| av专区在线播放| 免费久久久久久久精品成人欧美视频 | 欧美97在线视频| 99热网站在线观看| 蜜桃久久精品国产亚洲av| 午夜av观看不卡| 日韩 亚洲 欧美在线| 国产伦精品一区二区三区四那| 亚洲性久久影院| 七月丁香在线播放| 国产欧美日韩一区二区三区在线 | 免费观看在线日韩| 美女内射精品一级片tv| 大又大粗又爽又黄少妇毛片口| 又大又黄又爽视频免费| 亚洲欧美日韩另类电影网站| av天堂中文字幕网| 亚洲色图综合在线观看| 日韩在线高清观看一区二区三区| 久久人人爽人人爽人人片va| 91成人精品电影| 国产真实伦视频高清在线观看| 久久久久精品性色| 夫妻性生交免费视频一级片| 国产黄片视频在线免费观看| kizo精华| 一级毛片电影观看| 久久国产精品男人的天堂亚洲 | 色5月婷婷丁香| √禁漫天堂资源中文www| 国产色婷婷99| 少妇人妻久久综合中文| 成年av动漫网址| 一本色道久久久久久精品综合| 亚洲av男天堂| 久久国产精品男人的天堂亚洲 | 精品午夜福利在线看| 亚洲人成网站在线观看播放| 亚洲欧美日韩卡通动漫| 亚洲欧美一区二区三区黑人 | 美女国产视频在线观看| 青春草视频在线免费观看| 青春草亚洲视频在线观看| 久久精品国产亚洲av涩爱| 少妇猛男粗大的猛烈进出视频| 中文字幕人妻丝袜制服| 亚洲精品成人av观看孕妇| 3wmmmm亚洲av在线观看| 在线观看一区二区三区激情| 中国国产av一级| 成人免费观看视频高清| 日韩亚洲欧美综合| 欧美日韩在线观看h| 国产乱人偷精品视频| 亚洲内射少妇av| 亚洲久久久国产精品| 一区二区三区免费毛片| 男女啪啪激烈高潮av片| 狠狠精品人妻久久久久久综合| 免费不卡的大黄色大毛片视频在线观看| 成人午夜精彩视频在线观看| 久久人人爽av亚洲精品天堂| 国产av精品麻豆| 最近2019中文字幕mv第一页| 久久精品久久久久久噜噜老黄| 久久久久久久亚洲中文字幕| 偷拍熟女少妇极品色| 女人久久www免费人成看片| 亚洲av免费高清在线观看| 在线观看免费日韩欧美大片 | 你懂的网址亚洲精品在线观看| 丝袜脚勾引网站| 91aial.com中文字幕在线观看| 乱人伦中国视频| 色哟哟·www| 在线精品无人区一区二区三| 夜夜骑夜夜射夜夜干| 亚洲精品乱码久久久久久按摩| 中文字幕亚洲精品专区| 2018国产大陆天天弄谢| 看免费成人av毛片| 亚洲四区av| 在线观看免费日韩欧美大片 | 免费观看在线日韩| 欧美3d第一页| 久久久久视频综合| 色5月婷婷丁香| 一区二区三区乱码不卡18| 91午夜精品亚洲一区二区三区| 欧美成人精品欧美一级黄| 亚洲自偷自拍三级| 一个人看视频在线观看www免费| 欧美日韩国产mv在线观看视频| 中文天堂在线官网| 国产爽快片一区二区三区| 一边亲一边摸免费视频| 岛国毛片在线播放| 丝袜脚勾引网站| 看非洲黑人一级黄片| 亚洲三级黄色毛片| 91在线精品国自产拍蜜月| 亚洲欧美精品自产自拍| 免费看日本二区| 精品午夜福利在线看| 一个人看视频在线观看www免费| 一区二区三区乱码不卡18| 国产精品国产三级专区第一集| 乱人伦中国视频| 国产视频首页在线观看| 人体艺术视频欧美日本| 在线观看www视频免费| 丰满人妻一区二区三区视频av| 日韩在线高清观看一区二区三区| 日韩欧美精品免费久久| 在线观看免费日韩欧美大片 | 久久99一区二区三区| 国产精品久久久久久精品古装| 成人国产av品久久久| 亚洲欧美一区二区三区黑人 | 黑人高潮一二区| 99re6热这里在线精品视频| av不卡在线播放| 哪个播放器可以免费观看大片| 久久国产精品男人的天堂亚洲 | 国产日韩一区二区三区精品不卡 | 国产黄频视频在线观看| tube8黄色片| 久久人人爽av亚洲精品天堂| 制服丝袜香蕉在线| 18禁动态无遮挡网站| 有码 亚洲区| 亚洲经典国产精华液单| 久久人人爽人人片av| 色吧在线观看| 久久久久久久久久成人| 成年人午夜在线观看视频| 免费人妻精品一区二区三区视频| 美女视频免费永久观看网站| 少妇丰满av| 精品亚洲成国产av| 国产亚洲91精品色在线| 免费看不卡的av| 久久97久久精品| 99视频精品全部免费 在线| 久久久久国产精品人妻一区二区| 久久久久久久久大av| 亚洲无线观看免费| 色婷婷久久久亚洲欧美| 国产欧美日韩综合在线一区二区 | 日韩三级伦理在线观看| 亚洲国产日韩一区二区| 乱系列少妇在线播放| 少妇人妻久久综合中文| 国产毛片在线视频| 在现免费观看毛片| 成人国产麻豆网| 国产精品人妻久久久久久| 婷婷色综合www| 精品久久久久久久久亚洲| 成人午夜精彩视频在线观看| 一级毛片我不卡| 如日韩欧美国产精品一区二区三区 | 香蕉精品网在线| 国产精品欧美亚洲77777| 99精国产麻豆久久婷婷| 在现免费观看毛片| 免费高清在线观看视频在线观看| 91精品国产九色| 久久精品国产自在天天线| 欧美性感艳星| 免费看光身美女| 又大又黄又爽视频免费| 久久精品熟女亚洲av麻豆精品| 久久久久久久精品精品| 蜜桃久久精品国产亚洲av| 日本wwww免费看| 91成人精品电影| 夫妻午夜视频| 亚洲国产日韩一区二区| 一本大道久久a久久精品| 精品人妻偷拍中文字幕| 特大巨黑吊av在线直播| 我的女老师完整版在线观看| 青春草视频在线免费观看| 在线观看美女被高潮喷水网站| 国产av精品麻豆| 少妇 在线观看| 成人国产麻豆网| 老女人水多毛片| 国产男女内射视频| 国产在线视频一区二区| 校园人妻丝袜中文字幕| 日本-黄色视频高清免费观看|